Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

18F-Fluorocholine PET/CT Is More Sensitive Than 11C-Methionine PET/CT for the Localization of Hyperfunctioning Parathyroid Tissue in Primary Hyperparathyroidism

Céline Mathey, Caroline Keyzer, Didier Blocklet, Gaetan Van Simaeys, Nicola Trotta, Simon Lacroix, Bernard Corvilain, Serge Goldman and Rodrigo Moreno-Reyes
Journal of Nuclear Medicine May 2022, 63 (5) 785-791; DOI: https://doi.org/10.2967/jnumed.121.262395
Céline Mathey
1Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Keyzer
2Department of Medical Imaging, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Blocklet
1Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaetan Van Simaeys
1Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Trotta
1Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Lacroix
1Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Corvilain
3Department of Endocrinology, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge Goldman
1Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodrigo Moreno-Reyes
1Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Hôpital Érasme, Université Libre de Bruxelles, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Flowchart. PCa = parathyroid carcinoma; PH = parathyroid hyperplasia.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Correlation between 18F-FCH (early [A] and late [B]) and 11C-MET uptake. ****P < 0.0001.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Patient 3. Coronal PET/CT images of 67-y-old woman with pHPT and inconclusive 99mTc-MIBI SPECT/CT (doubtful right inferior focus). (A) 11C-MET images show asymmetric thyroid lobes with lower extension on left (arrow). (B) 18F-FCHL images shows nodular uptake under base of left thyroid lobe (arrow). (C) PET/CT images detail nodular aspect of 18F-FCH uptake (arrow) in PA confirmed at histopathologic analysis.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Patient Characteristics (n = 53)

    CharacteristicValueNormal value
    Sex (M/F)16/37
    Age (y)58 ± 16
    Body mass index (kg/m2)28.2 ± 5.5
    Prior parathyroidectomy7 (13)
    Prior
     99mTc-MIBI SPECT/CT
      Negative38 (72)
      Inconclusive15 (28)
     Ultrasonography35 (66)
     Other9 (17)
    Baseline laboratory values
     PTH (ng/L)72.0 (54–101)4–49
     Calcium (mmol/L)2.67 (2.62–2.69)2.12–2.62
     Phosphorus (mmol/L)0.75 ± 0.170.81–1.45
     25-hydroxycholecalciferol (ng/mL)24.74 ± 8.9730–80
    11C-MET results
     Positive25 (47)
     Negative*28 (53)
    18F-FCH results
     Positive39 (74)
     Negative*14 (26)
    Surgical results (n = 26)
     Pathologic parathyroid tissue found24 (92)
     Biologic normalization during follow-up21 (81)†
    • * Negative imaging includes negative or inconclusive results.

    • ↵†2 patients were lost to follow-up.

    • Qualitative data are number and percentage; continuous data are mean ± SD; nonnormal continuous data are median and 25th–75th percentiles (D’Agostino–Pearson omnibus test).

    • View popup
    TABLE 2.

    Contingency Tables

    ParameterPositive 18F-FCHNegative 18F-FCHTotal
    Per patient
     Positive 11C-MET25025
     Negative 11C-MET141428
     Total391453
    Per lesion
     Positive 11C-MET28038
     Negative 11C-MET191837
     Total471875

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (5)
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-Fluorocholine PET/CT Is More Sensitive Than 11C-Methionine PET/CT for the Localization of Hyperfunctioning Parathyroid Tissue in Primary Hyperparathyroidism
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-Fluorocholine PET/CT Is More Sensitive Than 11C-Methionine PET/CT for the Localization of Hyperfunctioning Parathyroid Tissue in Primary Hyperparathyroidism
Céline Mathey, Caroline Keyzer, Didier Blocklet, Gaetan Van Simaeys, Nicola Trotta, Simon Lacroix, Bernard Corvilain, Serge Goldman, Rodrigo Moreno-Reyes
Journal of Nuclear Medicine May 2022, 63 (5) 785-791; DOI: 10.2967/jnumed.121.262395

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-Fluorocholine PET/CT Is More Sensitive Than 11C-Methionine PET/CT for the Localization of Hyperfunctioning Parathyroid Tissue in Primary Hyperparathyroidism
Céline Mathey, Caroline Keyzer, Didier Blocklet, Gaetan Van Simaeys, Nicola Trotta, Simon Lacroix, Bernard Corvilain, Serge Goldman, Rodrigo Moreno-Reyes
Journal of Nuclear Medicine May 2022, 63 (5) 785-791; DOI: 10.2967/jnumed.121.262395
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • primary hyperparathyroidism
  • parathyroid adenoma
  • 18F-fluorocholine
  • 11C-methionine
  • PET/CT
SNMMI

© 2025 SNMMI

Powered by HighWire